CLINICAL_TRIALS
trial_result
· 2022-11-02
Clinical Trial Update: A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 trial update for LY3209590 in type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2022-11-02